Grifols | GRFS - Ebitda





Ebitda Cambiamento Data
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Arca Biopharma USD -25.07M 5.23M 2025-03
aTyr Pharma USD 25.85M 52.43M 2025-12
Bio Path USD -3.21M 631K 2025-03
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Capricor Therapeutics USD -27.23M 2.66M 2025-06
Cara Therapeutics USD -2.39M 3.16M 2025-03
Esperion Therapeutics USD -9.93M 24.99M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Grifols EUR 482.04M 7.04M 2025-09
Immunic USD -22.78M 753K 2024-06
Infinity Pharmaceuticals USD -10.01M 1.39M 2023-06
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Nektar Therapeutics USD -31.81M 70K 2023-09
TherapeuticsMD USD -1.64M 700K 2023-09